摘要 |
A process for the manufacture of the racemic compound of the formula (I), its R-enantiomer (formula R-(I)) and its S-enantiomer (formula S-(I)),and pharmaceutically acceptable salts and/or solvates thereof, as well as new intermediates obtained and used in the process. |